Delivery Order SPE2DB20D7059-SPE2DB25FQFY3
- Not listed
- The Defense Logistics Agency awarded a $34,561.46 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packaging) valued at $14,433.09. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The order will be fulfilled from the vendor's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $37,329.50 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) on September 4, 2025, with completion targeted for September 5, 2025. This non-competed, firm fixed-price delivery order is issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December...
- The Defense Logistics Agency awarded a delivery order valued at $17,461.79 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) under a firm fixed price contract type. This non-competitive delivery order was issued on June 16, 2025, with an ultimate completion date of June 17, 2025. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $8,501.91 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count packages) on December 10, 2025, with completion expected by December 11, 2025. This firm fixed-price, competitively awarded contract with no set-aside designation will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $8,296.38 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count packaging). This is a firm fixed-price delivery order with no set-aside designation, awarded on May 16, 2025, with an ultimate completion date of May 19, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $63,097.82 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of NURTEC ODT 75 MG tablets (quantity: 8 units). This firm fixed-price delivery order, which is not set-aside, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 1, 2025. The award represents a single transaction under AmerisourceBergen's broader federal pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $2,999.35 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on July 24, 2025, with completion scheduled for July 25, 2025. This non-set-aside, firm fixed-price delivery order represents a pharmaceutical supply transaction supporting federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills the order from its...
- The Defense Logistics Agency awarded a $20,329.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of NURTEC ODT 75 MG tablets (eight-count units). The contract, which is non-set-aside and competitively awarded, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 15, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency's Medical Supply Chain issued a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of NURTEC ODT 75 mg tablets (8 count) with a ceiling value of $33,387.60. This is a firm fixed price, non-set-aside competitive award with an ultimate completion date of September 22, 2025. The order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters....
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQFY3Delivery Order
The Defense Logistics Agency awarded a $4,546.64 delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of NURTEC ODT 75 MG tablets (8-count units). This is a firm fixed price, non-set-aside contract with a completion date of May 9, 2025, and performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company was competitively selected for this delivery order, consistent with its broader portfolio of non-set-aside federal awards across multiple therapeutic domains. NURTEC ODT is a migraine treatment medication, reflecting the company's role in supplying specialty pharmaceuticals and neurological treatments to Department of Defense medical supply chains and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 5/8/25 |